BDNF and EGF act on downstream receptors [tropomyosin receptor kinase b (TrkB) and EGFR] on the surface of cancer cells and activate pathways ensuring cancer cell invasiveness (Embi et al., 2012; Kim et al., 2014). This evidence concerns the gene BDNF and cancer.